The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease.
Diabetol Metab Syndr
; 12: 37, 2020.
Article
in En
| MEDLINE
| ID: mdl-32377235
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Diabetol Metab Syndr
Year:
2020
Document type:
Article
Country of publication: